![Chronic Pain Attack [Oh my God, babe??] [Public Place] [Let's Get You Home]](https://i.ytimg.com/vi/3UPe96zlzpk/hqdefault_live.jpg "Chronic Pain Attack [Oh my God, babe??] [Public Place] [Let's Get You Home]")
){kind=link}
Barbara Burtness, MD, Fox Chase Cancer Center, discusses results of EKOG E 130 on induction chemo followed by cetuximab with low-dose versus standard dose IMRT in patients with HPV-associated resectable squamous cell carcinoma of the oropharynx.
Barbara Burtness, MD, Fox Chase Cancer Center, discusses results of EKOG E 130 on induction chemo followed by cetuximab with low-dose versus standard dose IMRT in patients with HPV-associated resectable squamous cell carcinoma of the oropharynx.
Thanks! Share it with your friends!
Barbara Burtness, MD, Fox Chase Cancer Center, discusses results of EKOG E 130 on induction chemo followed by cetuximab with low-dose versus standard dose IMRT in patients with HPV-associated resectable squamous cell carcinoma of the oropharynx.
Comments